Ad
related to: 2017 aap clinical practice guideline
Search results
Results from the WOW.Com Content Network
In 2016, the American Academy of Pediatrics (AAP) published a clinical practice guideling recommending the replacement of ALTE with a new term, brief resolved unexplained event (BRUE). [2] The guidelines state that the term ALTE is still applicable with key differences between ALTE and BRUE.
The AAP News is the academy's official news magazine, [8] and Pediatrics is its flagship journal. [9] The AAP issues a weekly report [10] on COVID-19 cases in the United States. States began reporting COVID-19 cases on September 17, 2020. The AAP tracked 587,948 child COVID-19 cases, 5,016 child hospitalizations, and 109 child deaths. [11]
A medical guideline (also called a clinical guideline, standard treatment guideline, or clinical practice guideline) is a document with the aim of guiding decisions and criteria regarding diagnosis, management, and treatment in specific areas of healthcare. Such documents have been in use for thousands of years during the entire history of medicine
Dr. Tanner points out that a 2016 clinical report from the AAP, which is referenced in the new guidelines, cautioned that teens might use unhealthy behaviors to try to lose weight. The report ...
The Glasgow coma scale (GCS) is a clinical scale utilized to measure the severity of the concussion. [15] The normal GCS can be used for children above the age of two, and a pediatric GCS has also been developed to assess the symptoms for children under the age of two. [16] [17]
The Holliday-Segar formula is a formula to help approximate water and caloric loss (and therefore the water requirements) using a patient's body weight. [1] Primarily aimed at pediatric patients, the Holliday-Segar formula is the most commonly used estimate of daily caloric requirements. [2]
According to the 2020 guidelines from the American Academy of Pediatrics (referred to as the AAP 2020 Guidelines), diagnosis of NAS is determined through clinical assessment, neonatal testing, as well as diagnosis by exclusion to make sure that there are no other potential causes for the neonatal symptoms. [29]
In its 2017 guideline on treating those with gender dysphoria, it recommends puberty blockers be started when the child has started puberty (Tanner Stage 2 for breast or genital development) and cross-sex hormones be started at 16, though they note "there may be compelling reasons to initiate sex hormone treatment prior to the age of 16 years ...
Ad
related to: 2017 aap clinical practice guideline